Improving Diabetes Care: The Model for Health Care Reform by Kahn, Richard & Anderson, John E.
Improving Diabetes Care: The Model for
Health Care Reform
RICHARD KAHN, PHD
1
JOHN E. ANDERSON, MD
2
A
s policy makers now debate the el-
ements of health care reform, the
medical management of diabetes is
an excellent “case study” and in nearly all
ways epitomizes the problems the coun-
try faces. The most obvious way in which
diabetes epitomizes the need for health
care reform is that chronic diseases, not
acute infectious disorders, are the current
and growing health-related ﬁnancial
drain on the country. Of the six leading
causes of death in the U.S., four are
chronic diseases (1). In 2005, 44% of
adult Americans had at least one chronic
condition, and diabetes (without compli-
cations), hypertension, and hyperlipid-
emia were the three most prevalent,
accounting for 31% of all reported
chronic disease (2).
Coupling the current impact of
chronicdiseasewiththeincreasesthatare
expected to occur (3), future health care
spending for diabetes is likely to worsen.
Lest one believe that the ﬁnancial burden
of health care does not reach the public
directly,EmanuelandFuchs(4)pointout
that government exacts its share through
taxationorbyreducingotherservicesthat
beneﬁtcitizens.Employerspassonhealth
care costs in the form of lower wages or
higher prices. As for direct spending by
the public, Paez et al. (2) reported that
out-of-pocket health care spending from
1996 to 2005 rose 45% (adjusted for in-
ﬂation and changing disease prevalence),
with the greatest growth occurring in
those with multiple chronic diseases, as
seen in those with diabetes.
Are we getting our money’s worth?
One might take relief if we were paying a
lot of money for health care and getting
stellar results, but by virtually every mea-
sure this is far from true. Comparing the
U.S. with other countries puts us near the
bottom on most measures of health status
among all developed countries (5). In the
U.S., slightly more than half of all adults
with diabetes receive recommended care
(6,7) and a much lower proportion have
adequate cardiovascular risk factor con-
trol (8).
The cost of American health care in
relation to the outcomes achieved sug-
gests that we should get better value for
our health care dollar and that diabetes
and its complications and associated co-
morbidities exemplify the problems we
have in our health care system. So, what
should change?
Health care reform versus health
ﬁnance reform
Much of the discussion on “health care
reform” is really centered on reforming
health care ﬁnancing and not on improv-
ing the organization and delivery of care.
When policy makers address the high
cost of Medicare or reducing the number
of uninsured, such reforms primarily ad-
dress ﬁnancing. There is not much evi-
dence that changes in the way money
moves within the health care system will
de facto result in better health outcomes
or produce greater value (i.e., getting the
most health beneﬁt per dollar spent).
Because it is unclear that proposals to
changehealthcareﬁnancingwillsubstan-
tially change the quality of care, it seems
reasonable to approach system reform by
ﬁrst addressing how care might be better
organized and delivered. Financial incen-
tives can then be provided to get the pub-
lic and health care professionals and their
institutions to change their behavior and
practice patterns.
Another important issue in the dis-
cussion on health care reform is the no-
tion that substantive changes will lead to
an overall reduction in the cost of health
care, or achieve “cost savings.” That is not
likely to happen. As our population in-
creases in absolute number, grows dis-
proportionately older, and thus
susceptible to more disease, and lives in a
world of expensive technological ad-
vancement, the likelihood that major
changes in health care ﬁnancing or deliv-
ery will reduce overall expenditures is
quite unlikely.
Thus, we should not view health care
as a way to save money, but rather as an
“item” purchased that provides beneﬁt
(value). Although there are net ﬁnancial
savings for speciﬁc populations resulting
from a few health-related interventions,
the overwhelming majority of interven-
tions cost more money than they save.
The discussion might therefore be better
framed as to what changes we should
make that can result in better outcomes:
how do we deliver care that is cost-
effective and reduces the burden of
chronic disease?
Prevention versus treatment
A commonly held belief is that the way to
reduce overall health care expenses is to
prevent disease from occurring. It may
seem intuitive that the high cost of treat-
ing diabetes or its complications must be
greater than the cost of lifestyle modiﬁca-
tion or pharmacotherapy to prevent dia-
betes. Yet the prevention of diabetes or its
complications is seldom cost-saving
(9,10), and the same is true for other
chronic diseases (11,12). The lifetime
cost of treating a large number of people
to prevent or postpone a much smaller
number of cases of diabetes or its compli-
cations extends life expectancy for a few.
And for them, other diseases arise with
their associated costs, all of which do not
favor prevention services in purely ﬁnan-
cial terms.
If the cost of prevention (or treat-
ment) can be reduced considerably, or if
preventive service can be taken out of the
health care system altogether and imple-
mented into another setting where the
overall cost is lower, then the cost of pre-
vention may be much less. In addition,
preventing disease potentially avoids and
certainly postpones suffering and may
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to quantify (e.g., impact on families),
which may make it preferable to
treatment.
To frame the prevention-treatment
debate more appropriately, we need to
know the comparative effectiveness be-
tween interventions and the cost-
effectiveness of all health care services.
Only then can we decide what our prior-
ities should be (13). This speaks to a
widely held recommendation for health
carereform(14–16).Thatis,weneedfor-
mal effectiveness and cost-effectiveness
studies for all medical services or at the
very least consider cost when developing
guidelines or making coverage decisions.
In addition, we should not require pre-
vention services to be more cost-effective
than other procedures, tests, or treat-
ments,includingsurgicalinterventionsor
end-of-life care.
A critical look at technology
Cost-effectiveness analyses are especially
important when new drugs or devices en-
ter the marketplace, since they are often
very costly and may provide only mar-
ginal improvements. When new technol-
ogy becomes heavily promoted and
widely adopted, it can become more dif-
ﬁcult to convince providers and consum-
ers that there are better, cheaper, or more
appropriate alternatives. In diabetes care,
we also face this dilemma: Increasingly
costlyandmorecomplextherapeuticreg-
imens are being implemented with little
knowledge of their comparative effective-
ness (17,18). Also, some technology has
gained widespread adoption without
much evidence that it is cost-effective for
all persons with diabetes (18,19). New
and relatively expensive technology in di-
abetes care may offer improvement in
only a subset of the diabetic population.
Moreover, the outcomes achieved in clin-
ical trials may not translate to the stan-
dard practice setting, where patient
motivation and providers skills in using
technologyarelikelytobemuchlessthan
in a trial setting.
The importance of information
technology
Most people with diabetes have other co-
morbid conditions, require medical man-
agement from multiple providers, and
have multiple ofﬁce visits. When medical
notes are often handwritten and inserted
into a paper medical record, the likeli-
hoodforerrorsincreasesandtheabilityto
coordinate care is diminished. Also, tests
and procedures are often unnecessarily
duplicated when multiple providers do
not have access to each others informa-
tion.Well-designedandeffectivelyimple-
mented electronic health records (EHRs)
are a critically important remedy. EHRs
offerautomatedandeasyaccesstopatient
information; the ability to process, orga-
nize, and report information across mul-
tiple providers; and seamless, more
explicit communication between provid-
ers, as well as between patients and their
providers (20).
However,informationtechnologyisa
tool, not an end onto itself. If patients are
not motivated or if a provider makes in-
appropriate therapeutic decisions con-
trary to medical evidence or in a system
organized around acute episodic care, the
promise of EHRs will not be realized.
These and other obstacles (21), particu-
larly the major economic outlay required
to implement EHRs in small practice set-
tings, have so far mostly conﬁned their
adoption to large group practices. Fortu-
nately, the new Obama administration is
willing to provide substantial resources
and incentives toward the adoption of
health information technology, and thus
this critical component of health care re-
form may be at hand.
Coordinated care and care
management
Intheearlyyearsofhavingdiabetes,good
glycemic control can be relatively easy to
attain and comorbid conditions may be
few, although as time progresses the dis-
ease burden increases and complications
inevitably arise. For a single physician to
provide comprehensive medical manage-
ment for someone with diabetes is virtu-
ally impossible.
Referring more patients to endocri-
nologists cannot be the answer, since the
demand exceeds the supply and the dis-
ciplineisnotgrowingasfastasthepatient
population. Also, a greater reliance on
specialists would likely require several
moredifferentspecialists,since,forexam-
ple, people with diabetes have on average
ﬁve different medical problems (22). Be-
cause comorbidities are seldom indepen-
dent of one another, people trained to
handle a variety of issues in a single en-
counter would seem to be more cost-
effective (23).
Increasing the number of primary
care physicians (PCPs) is also unrealistic
when specialty medicine pays much
more, and medical school enrollment is
not keeping up with the incidence of
chronic disease and the growth in ambu-
latory care visits (24). Thus, PCPs will be
in increasingly short supply, and because
they provide more of the care to the dis-
advantaged and minority populations
(i.e., those with a greater propensity to
develop diabetes), the disparities we now
see may only worsen (25). The outlook
for growth in other health professional
disciplines is not appreciably better.
The complexity of chronic diseases
has led to the recommendation that such
care be distributed across a multidisci-
plinary team (26), coordinated by a PCP
or in some cases a specialist. This concept
goes beyond case management, where
treatment is tailored to patients’ condi-
tions and centered on acute goals of ther-
apy and often operates independently of
patients’ primary physicians. This new
model of care has been termed the “pa-
tient-centered medical home” (PCMH).
Its primary elements are that it is team-
based and coordinated and directed by a
single physician, resulting in well-
orchestrated, continuous, comprehen-
sive, and timely care that (hopefully)
reduces the overuse and misuse of ser-
vices and leads to better outcomes at re-
duced cost (27,28).
In the management of diabetes, a pa-
tient-centered multidisciplinary team has
longbeenadvocated(29)anditselements
deﬁned (30). But in practice it has been
generally conﬁned to an endocrinologist
and diabetes educator(s). Many success-
ful and innovative approaches to diabetes
management that represent a hybrid be-
tween case management and the PCMH
have been described and could serve as
lessons for what could or does not work
(31–34).
Whether the PCMH or some version
of it can produce the results it promises is
unclear, and effective care coordination
has had problems (26). Nonetheless, as
chronic care supplants acute care as the
dominantdriverofhealthcarecosts,there
is a groundswell of opinion that the cur-
rent model of physician-directed, visit-
centered care must be replaced.
Measuring outcomes and paying for
quality
If a well-coordinated multidisciplinary
team approach to chronic care is to be-
comewidespread,qualityassessmentand
paymentreformiscritical.Otherwise,any
one of the team members can avoid ac-
countability if the desired outcomes are
notattained,eventhougheveryonemight
be asking for payment. The use of EHRs
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contributions of team members because
of their explicit nature and their ability to
be tailored to the interventions delivered.
Another concern is that chronic care
requires far more cognitive services than
tests and procedures, and it has been dif-
ﬁcult for providers of chronic care to
achieve appropriate reimbursement. In
the PCMH model, the care coordinator
would spend much more time communi-
cating with other clinicians and commu-
nity agencies and would likely be in
greater contact with a patient than is now
the case. Other clinicians on the team
would potentially have similar obliga-
tions. Under current reimbursement
schemes, much of this time goes uncom-
pensated or at best is poorly compen-
sated, and there are likely other team
members who currently are rarely reim-
bursed(e.g.,pharmacistsandcommunity
health workers).
Nearly all ambulatory visits are now
paid on a per-visit, fee-for-service basis,
with payment independent of the quality
of care delivered. This opacity of perfor-
mance, combined with a payment system
that does not fully reimburse cognitive
services and encourages the overuse of
compensated services, has led to reforms
that link pay to performance. Such a pay-
mentmodelisrelativelyeasytoachievein
integrated systems that provide compre-
hensive care management for an entire
population (e.g., all employees of a com-
pany),withthesystemreimbursedforthe
overall population’s health outcomes.
Where integrated systems do not ex-
ist, other payment methods will be neces-
sary(35).Paymentcouldbestructuredon
a risk-adjusted per-patient basis, with in-
centives for achieving desired intermedi-
ateoutcomesorincentivesforareduction
in overall costs such as avoiding hospital-
ization. The pay-for-performance para-
digm could be extended to patients as
well (36). Healthy behaviors should be
rewarded, not unlike current pay-for-
performance systems directed only to
physician services.
In addition to payment reform, we
need major changes in public health pol-
icy that lessen the reliance on medical
care. To reduce the incidence of diabetes,
we need public debate on national legis-
lation to incent the prevention of excess
weightgain,promoteweightloss,anden-
courage healthy diet patterns and physi-
cal activity. Although we will likely wind
upspendingmoremoneyon“health,”the
productivity of our population will im-
prove, and people will stay healthy
longer.
Barriers to health care reform
Despite the current ﬁscal crisis, it is by no
means certain we will soon see meaning-
ful health care reform. It seems likely,
however, that we will ﬁrst get legislation
that changes health ﬁnancing in the form
of health insurance for more of the now
uninsured. Conversely, major changes to
reduce the incidence of diabetes (or other
chronic diseases) or major initiatives that
improve outcomes will require system re-
form,i.e.,whodoeswhat,howwepayfor
care, and where care is delivered.
Fuchs(37,38)characterizesthebarri-
ers to reform as 1) a preference for the
statusquo;therearemanydisciplinesand
organizations with (often opposing)
stakes in the current way of doing busi-
ness such that any proposed change is
bound to rally the opposition. 2) The op-
position has greater resolve than the
change agents. Those who might proﬁt
from a new order are not as passionate as
thosewhomightlose.3)Uncertaintyover
exactly what to do. There are so many
opinions about what should change and
how that without a commonly held ap-
proach, inertia rules.
What you can do
Fuchs (38) believes that one way reform
will come about is when the nation is in
crisis mode. Readers of this journal well
know of the growing diabetes epidemic,
the inordinate cost of diabetes, and the
current shortcomings in diabetes care.
With this detailed knowledge of the
problems, now is the time to ratchet up
our concern. If reform is to occur, Amer-
icans need to hear more often and loudly
about the problems we face. The Ameri-
can Diabetes Association has created a
thoughtful list of health care and ﬁnance
reform recommendations (39) that will
serve as the blueprint for what the Asso-
ciation advocates in the reform debate.
Your active participation in this process is
critically important.
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